Laboratory：Akiruno
0 results
Selected search options |
- TOP
- gene-related test
- genetic tests for malignant tumor (solid tumor)
- Oncomine DxTT Multi Research (Thyroid Cancer) FF（Suspended beyond orders placed 06-14-2024）
Laboratory：Akiruno
○Oncomine DxTT Multi Research (Thyroid Cancer) FF（Suspended beyond orders placed 06-14-2024）
CODE：00L91 9
-
TEST NAME
SPECIMEN
REQUIREMENT
（ｍL） CONTAINER CAP COLOR STORE
TEMPERATURE
(STABILITY) TURNAROUND
TIME (DAY) METHODOLOGY REFERENCE RANGE
(UNIT) -
Oncomine DxTT Multi Research (Thyroid Cancer) FF（Suspended beyond orders placed 06-14-2024）
tissue
100mg
ARR
6-11 Next Generation Sequencing (NGS)A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments.
COMMENT
The purpose of this study is to analyzeRET gene mutation and RET fusion gene in genomic DNA and RNA extracted from cancer tissue to determine the indication of the drugs listed in the attached table for thyroid cancer and medullary thyroid cancer.
The available days are Monday to Friday.
Please make sure that the material contains the tumor site before submitting it. Please avoid duplicate requests with other items. Since this test method is more susceptible to contamination, please handle the specimens with care when collecting them.
When requesting this test, please be sure to also request the nucleic acid extraction item (item code No.: M961 0).●Notes
After collecting the specimen, please process it immediately. Please note that if the number of cells in the submitted specimen is low, the test may not be possible.
CONTAINER
ARR 旧容器記号 r A
滅菌ポリスピッツ
貯蔵方法：室温
supplementary information
対象遺伝子変異等と関連する医薬品および適応がん腫
| 遺伝子変異等 | がん腫 | 関連する医薬品 |
|---|---|---|
| RET融合遺伝子 | 甲状腺癌 | セルペルカチニブ |
| RET遺伝子変異 | 甲状腺髄様癌 |
